1 Pharm. D Intern, Nazareth College of Pharmacy, Othera , Thiruvalla, Kerala, India.
2 Department of General Medicine, Believers Church Medical College Hospital, Thiruvalla, India.
Received on 23 June 2023; revised on 10 August 2021; accepted on 13 August 2023
Piperacillin-tazobactam is a commonly used antibiotic that belongs to penicillin and beta-lactam inhibitors, which has a wide range of gram-negative bacteria and limited gram-positive activity. This case report presents one of the rare ADR of piperacillin–tazobactam –thrombocytopenia where a dramatic improvement within 24hrs in platelet count was observed after withdrawing the drug. Few cases of piperacillin tazobactam-induced thrombocytopenia have been reported.
Piperacillin-tazobactam; Thrombocytopenia; Multi-drug-resistant; Adverse Drug Reaction
Preview Article PDF
Nikhil M Sunny, Neha Susan Vinu and S. K Mathew. Piperacillin-tazobactam induced thrombocytopenia: A case report. International Journal of Science and Research Archive, 2023, 09(02), 739–741. Article DOI: https://doi.org/10.30574/ijsra.2023.9.2.0628
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0